Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Ganeden Biotech

Request full access

Science-backed probiotic ingredient for fortifying foods and beverages with digestive and immune health benefits

Mayfield Heights, United StatesFounded 1997Food

About Ganeden Biotech

GanedenBC30, a brand under Kerry's nutrition and wellness portfolio, specializes in providing a spore-forming probiotic ingredient known as Bacillus coagulans GBI-30, 6086. This probiotic is designed to remain viable through various manufacturing processes and the acidic environment of the stomach, making it ideal for fortifying everyday foods, beverages, and companion animal products. The company operates in the functional food and beverage market, targeting manufacturers looking to enhance their products with digestive and immune health benefits. GanedenBC30 generates revenue by supplying this specialized probiotic ingredient to product manufacturers, supported by over 25 published research papers validating its efficacy. The business model focuses on B2B relationships, providing a science-backed, hardy probiotic solution that meets consumer demand for health-focused products.

Source: Dealroom company data

At a glance

Status
Acquired
Employees
14
Open positions
None listed
Dealroom signal
20.0/100
Industry
Food

Funding history

2 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
ACQUISITION✓Exit Oct 2017 $0 — Kerry —
EARLY VC✓Equity / VC Nov 2007 $12M $48M DSM Venturing · Capital Resource Partners · DSM —
Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Ganeden Biotech website traffic

Latest recorded traffic for Ganeden Biotech is 480 monthly website visits. Ganeden Biotech's team grew 0% over the past year.

Latest monthly visits480 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Ganeden Biotech in the Mayfield Heights ecosystem

Live from Dealroom

The Ganeden Biotech office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

4 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A3 investors entered at this stage

  • Capital Resource Partners
  • DSM
  • DSM Venturing

Other known investors1 additional known investor

  • Kerry
Employees 14 total headcount
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Ganeden Biotech on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Ganeden Biotech’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.